Clinical Trial Update: Efficacy and Safety of Insulin RinGlar® Compared to Lantus® SoloStar® in Type 1 Diabetes Mellitus Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Insulin RinGlar to Lantus SoloStar in type 1 diabetes patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin RinGlar (insulin)
• Lantus SoloStar (Insulin glargine)

Snippet

Sponsor: Geropharm | Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus | Phase 3 | Status: COMPLETED